News

Analytik Jena Announces Forecast for the 2013/2014 Financial Year

Jena, Germany, April 29, 2014 — Analytik Jena AG (ISIN: DE0005213508, Market segment: Prime Standard, Stock market symbol: AJA) expects to achieve sales of between EUR 103.0 m and EUR 105.0 m in the instrument business for the current 2013/2014 financial year, without taking into account project business. These figures were announced today by the manufacturer of analytical measuring technology, Life Science instruments, and optoelectronics during its General Meeting at its headquarters in Jena, Germany. In the previous financial year, Analytik Jena generated revenue of EUR 97.7 m.

With regard to the project business revenue of AJZ Engineering, whose sales are included in total Group sales since October 2013 and which traditionally realizes the majority of its orders in Russia, Analytik Jena did not make any predictions for the financial year due to the current crisis in Ukraine.

Analytik Jena expects earnings before interest and taxes (EBIT) of approximately EUR 3.0 m (previous year: EUR 2.1 m) at the Group level. With regard to operational business, Analytik Jena is expecting stabilization in the second half of the current financial year in all three business units. Developments in China, the largest export market, continue to be encouraging, particularly in Analytical Instrumentation, while the phase of restructuring at the Japanese subsidiary is not yet completed. The Life Science business is experiencing positive development at UVP, the new US subsidiary, but is still influenced by strong pricing pressures and therefore is achieving much lower sales figures in the business unit and especially in the PCR instruments.

By the end of the first half of the 2013/2014 financial year, Analytik Jena AG generated consolidated revenue of EUR 62.8 m (previous year EUR 46.9 m) and thus 33.7 % more than in the previous year. Total sales included sales of EUR 12.0 m from AJZ Engineering GmbH, in which Analytik Jena reacquired majority control in October 2013. The instrument business generated sales of EUR 50.8 m after six months, which represents an increase of 8.2 %. Earnings before interest, taxes, depreciation, and amortization (EBITDA) amounted to EUR 3.6 m (previous year: EUR 4.7 m). Earnings before interest and taxes (EBIT) amounted to EUR 1.1 m (previous year: EUR 2.6 m). The earnings per share (EPS) amounted to EUR -0.22 (previous year: EUR 0.05).

This information is based on preliminary key financial figures. The Company will release the complete key figures on the second quarter and first half of the 2013/2014 financial year on May 15, 2014.